Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

XenoPort, Inc. announced that it is offering to sell, subject to market and other conditions, 2,500,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. XenoPort also intends to grant the underwriters a 30-day option to purchase up to an aggregate of 375,000 additional shares of common stock to cover over-allotments, if any. All of the shares in the offering are to be sold by XenoPort.

Today in Popular Press...keeping you current

Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President
BayNews International, 12/03/09

Abbott and the Abbott Fund Honored With Corporate Citizenship Award for International Community Service
Abbott, 12/03/09

Abbotts Ibis Technology Named One of the Top Innovations for 2009 by The Scientist
Abbott, 12/03/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address